Core Viewpoint - China's technological strength in the AI sector has garnered global attention, highlighting the importance of capital markets in supporting technological innovation and nurturing new productive forces [1][2]. Group 1: Capital Market Support for Technology - Since the establishment of the Sci-Tech Innovation Board, 23 unprofitable innovative pharmaceutical companies have gone public, raising nearly 70 billion yuan, which has provided a foundation for continuous R&D investment and innovation [1]. - The government work report emphasizes "promoting high-level technological self-reliance," indicating that capital markets are essential for achieving this goal [2]. - Suggestions from representatives include allowing loss-making projects related to "bottleneck" technologies to go public for financing, thereby increasing IPO supply for tech companies [2][3]. Group 2: Regulatory and Policy Developments - The pace of IPOs could be accelerated to inject "fresh blood" into the capital market, allowing quality tech companies to gain more financing support [3]. - The China Securities Regulatory Commission (CSRC) plans to enhance support mechanisms specifically for tech companies, including the implementation of more inclusive listing standards [3][4]. - The establishment of a national venture capital guidance fund is expected to attract nearly 1 trillion yuan in local and social capital to invest in tech companies [3]. Group 3: Future Outlook - A comprehensive framework is being developed to empower technological innovation through capital markets, with expectations that many tech companies will achieve commercialization similar to innovative pharmaceutical firms [4].
【投资者点题 代表委员共答】助力科技创新 资本市场大有可为、必有作为
证券时报·2025-03-07 00:33